Who is sponsoring NCT05591586?

NCT05591586 is sponsored by Seattle Children's Hospital.

What drugs are being tested in NCT05591586?

Interventions in NCT05591586: Web based educational modules, mobile video interpreting (mVI) access.

What condition does NCT05591586 study?

NCT05591586 studies Limited English Proficiency.

Is NCT05591586 still recruiting?

NCT05591586 is currently active, enrolled. Last updated 23 January 2026.

Last reviewed 2026-01-23 · How we verify

NCT05591586: mVOCAL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobile Video Interpretation to Optimize Communication Across Language Barriers

Active, enrolled NA Last updated 23 January 2026

What this trial tests

NA trial testing Web based educational modules in Limited English Proficiency in 6,669 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

24 October 2022

Primary endpoint
2 September 2025

31 August 2026

Quick facts

Lead sponsor	Seattle Children's Hospital
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	6,669
Start date	24 October 2022
Primary completion	2 September 2025
Estimated completion	31 August 2026
Sites	1 location across United States

Drugs / interventions tested

Web based educational modules
mobile video interpreting (mVI) access

Conditions studied

Limited English Proficiency — all drugs for Limited English Proficiency →

Sponsor

Seattle Children's Hospital

Who can join

Eligibility, any sex, with Limited English Proficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients and families with limited English proficiency (LEP) and/or who use a language other than English for medical care (LOE) experience substantial barriers to communication in the healthcare setting, leading to medical care that is less safe, less efficient, less effective, and inequitable. Professional interpreter use has repeatedly been shown to improve outcomes and reduce disparities, yet it remains widely underused. This study will test two discrete, scalable implementation strategies for improving professional interpreter use in primary care, while collecting detailed information about mechanisms of action and costs that will be applicable to many sites of care and contribute meaningfully to the goal of reducing communication-based disparities. The investigators hypothesize that improving provider knowledge, confidence, and interpreter access will change behavior under real-world conditions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A sequential, multiple assignment randomized trial comparing web-based education to mobile video interpreter access for improving provider interpreter use in primary care clinics: the mVOCAL hybrid type 3 study protocol.
Lion KC, Zhou C, Fishman P, Senturia K, et al · · 2023 · cited 4× · PMID 36915138 · DOI 10.1186/s13012-023-01263-6

Verify or expand the search:

Other Seattle Children's Hospital trials

Trials by the same sponsor.

NCT07522112 — Evaluating a Shared Decision-making Intervention for Families About Firearm Storage · NA · not yet recruiting
NCT06864611 — Evaluating Huddles as a Novel Approach to Improving Concussion Safety · NA · not yet recruiting
NCT07424157 — Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products · not yet recruiting
NCT07148050 — Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimer · Phase 1 · recruiting
NCT07097792 — Concussion Recovery and Support Program · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05591586 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seattle Children's Hospital
Last refreshed: 23 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05591586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing